Cytena

Exited

Cytena develops single-cell printing technology for cell research and professional diagnostics.

Total raised

€3.0M

€3,000,000

Funding rounds

Investors

distinct backers

Active since

2018-12

latest 2018-12

Funding by year

EUR raised per year

1 rounds

Date	Stage	Amount	Investors
2019-01-01	Series A	€3.0M	High-Tech Gründerfonds	View deal →

Type

acquisition

Date

Dec 2019

Value

—

Acquiror

CELLINK (US)

same sector or country